70
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients

, , , , , & show all
Pages 897-901 | Published online: 26 May 2017

References

  • GauthierSReisbergBZaudigMMild cognitive impairmentLancet20063671262127016631882
  • Alzheimer’s Association2016 Alzheimer’s disease facts and figuresAlzheimers Dement201612445950927570871
  • National Statistical Office (NSO)2014 Survey of Older Persons in ThailandBangkokNational Statistical Office2014
  • QuerfurthHWLaFerlaFMAlzheimer’s diseaseN Eng J Med2010362329344
  • PerryEMcKeithIBallardCButyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodiesNeurology2003601852185312796550
  • MesulamMMGeulaCButyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementiaAnn Neurol1994367227277979218
  • Gómez-RamosPBourasCMoránMAUltrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer’s disease patientsBrain Res199464017248004445
  • ReitzCMayeuxRUse of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementiaJ Alzheimers Dis20101922925120061642
  • BartelsCFJensenFSLockridgeODNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sitesAm J Hum Genet1992505108611031570838
  • HolmesCBallardCLehmannDRate of progression of cognitive decline in Alzheimer’s disease: effect of butyrylcholinesterase K gene variationJ Neurol Neurosurg Psychiatr200576564064315834019
  • Alvarez-ArcayaACombarrosOLlorcaJThe butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer’s disease in womenActa Neurol Scand2000102635035311125748
  • Deniz-NaranjoMCMunoz-FernandezCAlemany-RodriguezMJButyrylcholinesterase, ApoE and Alzheimer’s disease in a population from the Canary Islands (Spain)Neurosci Lett20074271343817923322
  • EvansRTWardellJOn the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian populationJ Med Genet1984212991026716425
  • LeeDWLiuHCLiuTYChiCWHongCJNo association between butyrylcholinesterase K-variant and Alzheimer’s disease in ChineseAm J Med Genet200096216716910893490
  • HiltunenMMannermaaAHelisalmiSButyrylcholinesterase K variant andapolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer’s disease patientsNeurosci Lett1998250169719696068
  • YamamotoYYasudaMMoriEMaedaKFailure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon 4 allele of the apolipoprotein gene in Japanese patients with Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry1999671949610369830
  • KiCSNaDLKimJWKimHJKimDKYoonBKNo association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer’s diseaseAm J Med Genet19998811311510206226
  • McIlroySPCrawfordVLDynanKBButyrylcholinesterase K variant is genetically associated with late onset Alzheimer’s disease in Northern IrelandJ Med Genet200037318218510699053
  • BartelsCFJensenFSLockridgeODNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sitesAm J Hum Genet1992505108611031570838
  • PanegyresPKMamotteCDSVasikaranSDWiltonSFabianVKakulasBAButyrylcholinesterase K variant and Alzheimer’s diseaseJ Neurol1999246536937010399868
  • BabaogluMOOcalTBayarBKayaalpSOBozkurtAFrequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish populationEur J Clin Pharmacol2004591287587714735258
  • GrubberaJMSaundersaAMCrane-GatherumARAnalysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K)Neurosci Lett1999269211511910430518
  • AlcantaraVMChautard-Freire-MariaEAPichethGVieiraMMFrequency of the CHE1*Kallele of serum cholinesterase in a sample from southern BrazilHum Hered1999406386390
  • MuangpaisanWAssantachaiPIntalapapornSPisansalakijDQuality of life of the community-based patients with mild cognitive impairmentGeriatr Gerontol Int200882808518713159
  • Train the Brain Forum CommitteeThai Mental State Examination (TMSE)Siriraj Hosp Gaz199345661674
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington, DCAmerican Psychiatric Association1994
  • PetersenRCDoodyRKurzACurrent concepts in mild cognitive impairmentArch Neurol200158121985199211735772
  • HughesCPBergLDanzigerWLCobenLAMartinRLA new clinical scale for the staging of dementiaBr J Psychiatry19821405665727104545
  • ReisbergBFerrisSHde LeonMJCrookTThe global deterioration scale for assessment of primary degenerative dementiaAm J Psychiatry19821399113611397114305
  • JeneseLRNielsenLRSchwartzMDetection of the plasma cholinesterase K variant by PCR using amplification-created restriction siteHum Herd19964612631
  • EllmanGLCourtneyKDAndresVJrFeather-StoneRMA new and rapid colorimetric determination of acetylcholinesterase activityBiochem Pharmacol19617889513726518
  • LehmannDJJohnstonCSmithADSynergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer’s diseaseHum Mol Genet1997611193319369302273
  • TilleyLMorganKGraingerJEvaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer’s diseaseEur J Hum Genet19997665966310482954
  • WiebuschHPoirierJSevignyPSchappertKFurther evidence for a synergistic association between APOE ε4 and BCHE-K in confirmed Alzheimer’s diseaseHum Genet199910415816310190327
  • RayganiAVZahraiMSoltanzadehADoostiMJavadiEPourmotabbedTAnalysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer’s diseaseNeurosci Lett20043712–314214615519745
  • SingletonABSmithGGibsonAMNo association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer’s diseaseHum Mol Genet1998759379399536100
  • BizzarroAGuglielmiVLomastroRBChE K variant is decreased in Alzheimer’s disease not in fronto-temporal dementiaJ Neural Transm (Vienna)2010117337738320058037
  • PodolyEShalevDEShenhar-TsarfatySThe butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathologyJ Biol Chem200928425171701717919383604
  • HolmesCBallardCLehmanDRate of progression of cognitive decline in Alzheimer’s disease: effect of butyrylcholinesterase K gene variationJ Neurol Neurosurg Psychiatry200576564064315834019
  • FerrisSNordbergASoininenHDarreh-ShoriTLaneRProgression from mild cognitive impairment to Alzheimer’s disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatmentPharmacogenet Genomics200919863564619617863
  • LaneRMHeYButyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotypeAlzheimers Dement201392e17e73